Literature DB >> 34171216

Fosfowash: Early proof of concept study investigating intravesical fosfomycin for recurrent urinary tract infections.

Blayne Welk1, Christopher Munday2, Jeremy Burton3, Richard J Baverstock4.   

Abstract

Entities:  

Year:  2021        PMID： 34171216      PMCID： PMC8631855          DOI： 10.5489/cuaj.7365

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  10 in total

1.  Antibiotic overuse: Stop the killing of beneficial bacteria.

Authors:  Martin Blaser
Journal:  Nature       Date:  2011-08-24       Impact factor: 49.962

2.  The use of intravesical gentamicin to treat recurrent urinary tract infections in lower urinary tract dysfunction.

Authors:  Paul Abrams; Hashim Hashim; Charles Tomson; Alasdair Macgowan; Rachel Skews; Katherine Warren
Journal:  Neurourol Urodyn       Date:  2017-05-15       Impact factor: 2.696

3.  Intravesical Gentamicin Treatment for Recurrent Urinary Tract Infections Caused by Multidrug Resistant Bacteria.

Authors:  Janneke E Stalenhoef; Cees van Nieuwkoop; Petra H Menken; Sandra T Bernards; Henk W Elzevier; Jaap T van Dissel
Journal:  J Urol       Date:  2019-03       Impact factor: 7.450

Review 4.  Fosfomycin.

Authors:  Matthew E Falagas; Evridiki K Vouloumanou; George Samonis; Konstantinos Z Vardakas
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

Review 5.  Prevention of Recurrent Urinary Tract Infections in Neurourology.

Authors:  Jürgen Pannek
Journal:  Eur Urol Focus       Date:  2020-02-13

6.  Gentamicin bladder instillations decrease symptomatic urinary tract infections in neurogenic bladder patients on intermittent catheterization.

Authors:  Lindsey Cox; Chang He; Jack Bevins; J Quentin Clemens; John T Stoffel; Anne P Cameron
Journal:  Can Urol Assoc J       Date:  2017-09       Impact factor: 1.862

7.  Susceptibility of urinary tract bacteria to fosfomycin.

Authors:  Sofia Maraki; George Samonis; Petros I Rafailidis; Evridiki K Vouloumanou; Emmanuel Mavromanolakis; Matthew E Falagas
Journal:  Antimicrob Agents Chemother       Date:  2009-08-17       Impact factor: 5.191

Review 8.  Use and Effectiveness of Antimicrobial Intravesical Treatment for Prophylaxis and Treatment of Recurrent Urinary Tract Infections (UTIs): a Systematic Review.

Authors:  Amelia Pietropaolo; Patrick Jones; Mike Moors; Brian Birch; Bhaskar K Somani
Journal:  Curr Urol Rep       Date:  2018-08-09       Impact factor: 3.092

Review 9.  Adult Neurogenic Lower Urinary Tract Dysfunction and Intermittent Catheterisation in a Community Setting: Risk Factors Model for Urinary Tract Infections.

Authors:  Michael Kennelly; Nikesh Thiruchelvam; Márcio Augusto Averbeck; Charalampos Konstatinidis; Emmanuel Chartier-Kastler; Pernille Trøjgaard; Rikke Vaabengaard; Andrei Krassioukov; Birte Petersen Jakobsen
Journal:  Adv Urol       Date:  2019-04-02

10.  Continuous low-dose antibiotic prophylaxis for adults with repeated urinary tract infections (AnTIC): a randomised, open-label trial.

Authors:  Holly Fisher; Yemi Oluboyede; Thomas Chadwick; Mohamed Abdel-Fattah; Catherine Brennand; Mandy Fader; Simon Harrison; Paul Hilton; James Larcombe; Paul Little; Doreen McClurg; Elaine McColl; James N'Dow; Laura Ternent; Nikesh Thiruchelvam; Anthony Timoney; Luke Vale; Katherine Walton; Alexander von Wilamowitz-Moellendorff; Jennifer Wilkinson; Ruth Wood; Robert Pickard
Journal:  Lancet Infect Dis       Date:  2018-06-28       Impact factor: 25.071
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.